Showing results (1871-1880 of 8,878) with videos related to

Sort By:
Pageof 888
BJU International|August 14, 2012
Expression and electrophysiological characteristics of P2X3 receptors in interstitial cells of Cajal in rats with partial bladder outlet obstructionYuxin Li, Li Xue, Qing Miao, et al.
BJU International|August 14, 2012
Is there a direct antimicrobial effect of botulinum neurotoxin type A?Jens Wöllner, Kathrin Schmidig, Flavia Gregorini, et al.
BJU International|August 14, 2012
The regulation of ATP release from the urothelium by adenosine and transepithelial potentialBryony M Dunning-Davies, Christopher H Fry, Dina Mansour, et al.
BJU International|August 14, 2012
Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2AYalcin Cirak, Umut Varol, Harika Atmaca, et al.
BJU International|August 14, 2012
Fluorescence diagnosis of bladder cancer: a novel in vivo approach using 5-aminolevulinic acid (ALA) dendrimersAurélie François, Sinan Battah, Alexander J MacRobert, et al.
BJU International|June 28, 2020
Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68 Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant?Michael Y Chen, Anthony Franklin, John Yaxley, et al.
BJU International|October 20, 2012
Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout ratesMassimo Polito, Gianluca d'Anzeo, Alessandro Conti, et al.
BJU International|May 8, 2023
Cancer detection and complications of transperineal prostate biopsy with antibiotics when indicatedLiselotte M S Boevé, Floride T Bloemendal, Katelijne C C de Bie, et al.
BJU International|June 4, 2014
The scientific basis for the use of biomaterials in stress urinary incontinence (SUI) and pelvic organ prolapse (POP)Marc Colaco, Jayadev Mettu, Gopal Badlani
BJU International|June 5, 2014
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trialMaria Pearse, Carol Fraser-Browne, Ian D Davis, et al.
Pageof 888